![Alison Long](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Long
Directeur/Bestuurslid bij
TAYSHA GENE THERAPIES, INC.
Vermogen: 745 263 $ op 31-07-2026
Profiel
Dr. Alison Long is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Medical Officer at Flightpath Biosciences, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Long was previously employed as a Chief Medical Officer by Anokion SA, a Chief Medical Officer by Kaleido Biosciences, Inc., a Chief Medical Officer by Freeline Therapeutics Holdings Ltd., and a Head-Clinical R&D by Spark Therapeutics, Inc. She received her undergraduate degree from the University of the Witwatersrand and a doctorate degree from George Mason University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 127.178 ( 0,05% ) | 745 263 $ | 31-07-2026 |
Actieve functies van Alison Long
| Bedrijven | Functie | Begin |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Directeur/Bestuurslid | 01-11-2023 |
Flightpath Biosciences, Inc.
 Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Eerdere bekende functies van Alison Long
| Bedrijven | Functie | Einde |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| KALEIDO BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
| SPARK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2020 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
Opleiding van Alison Long
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Flightpath Biosciences, Inc.
Flightpath Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
